Great progress during Q3 – more to come
Successful outcome of pharmacokinetic trial (phase II)The original release included a small typo, that clinical trial 0206 investigating the pharmacokinetics of CT001 in children aged 1-17 undergoing elective surgical procedures, was a phase I study – it was of course a phase II study. We apologise for the mistake. Primary endpoint was successfully met by obtaining pharmacokinetic data in this age group, showing relevant clinical exposure ranges. In addition, secondary objectives of safety, pain assessment, and acceptance of intranasal administration was at an acceptable level (meaning